37
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      2016 European Guidelines on cardiovascular disease prevention in clinical practice : The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)

      , , 1 , 2 , 3 , 4 , 1 , 1 , 1 , 1 , 1 , 5 , 3 , 1 , 6 , 1 , 1 , 1 , 7 , 1 , 8 , 1 , 1 , 9 , 10 , 1 , , , 1 , 6 , 1 , 1 , 1 , 3 , 1 , 1 , 8 , 1 , 1 , 1 , 1 , 10 , 1 , 1 , 1 , 1 , 7 , 5 , 1 , 1 , 1 , 1 , 1 , 2 , 9 , 4 , 1 , 1 , Authors/Task Force Members, Additional Contributor: Simone Binno (Italy), Document Reviewers:
      European Journal of Preventive Cardiology
      SAGE Publications

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references532

          • Record: found
          • Abstract: found
          • Article: not found

          A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

          The Lancet, 380(9859), 2224-2260
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

            The effects of empagliflozin, an inhibitor of sodium-glucose cotransporter 2, in addition to standard care, on cardiovascular morbidity and mortality in patients with type 2 diabetes at high cardiovascular risk are not known.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              General cardiovascular risk profile for use in primary care: the Framingham Heart Study.

              Separate multivariable risk algorithms are commonly used to assess risk of specific atherosclerotic cardiovascular disease (CVD) events, ie, coronary heart disease, cerebrovascular disease, peripheral vascular disease, and heart failure. The present report presents a single multivariable risk function that predicts risk of developing all CVD and of its constituents. We used Cox proportional-hazards regression to evaluate the risk of developing a first CVD event in 8491 Framingham study participants (mean age, 49 years; 4522 women) who attended a routine examination between 30 and 74 years of age and were free of CVD. Sex-specific multivariable risk functions ("general CVD" algorithms) were derived that incorporated age, total and high-density lipoprotein cholesterol, systolic blood pressure, treatment for hypertension, smoking, and diabetes status. We assessed the performance of the general CVD algorithms for predicting individual CVD events (coronary heart disease, stroke, peripheral artery disease, or heart failure). Over 12 years of follow-up, 1174 participants (456 women) developed a first CVD event. All traditional risk factors evaluated predicted CVD risk (multivariable-adjusted P<0.0001). The general CVD algorithm demonstrated good discrimination (C statistic, 0.763 [men] and 0.793 [women]) and calibration. Simple adjustments to the general CVD risk algorithms allowed estimation of the risks of each CVD component. Two simple risk scores are presented, 1 based on all traditional risk factors and the other based on non-laboratory-based predictors. A sex-specific multivariable risk factor algorithm can be conveniently used to assess general CVD risk and risk of individual CVD events (coronary, cerebrovascular, and peripheral arterial disease and heart failure). The estimated absolute CVD event rates can be used to quantify risk and to guide preventive care.
                Bookmark

                Author and article information

                Journal
                European Journal of Preventive Cardiology
                Eur J Prev Cardiolog
                SAGE Publications
                2047-4873
                2047-4881
                April 14 2016
                July 2016
                June 27 2016
                July 2016
                : 23
                : 11
                : NP1-NP96
                Affiliations
                [1 ]Societies: 1European Society of Cardiology (ESC)
                [2 ]International Society of Behavioural Medicine (ISBM)
                [3 ]WONCA Europe.
                [4 ]European Atherosclerosis Society (EAS)
                [5 ]International Diabetes Federation European Region (IDF Europe)
                [6 ]International Federation of Sport Medicine (FIMS)
                [7 ]European Society of Hypertension (ESH)
                [8 ]European Association for the Study of Diabetes (EASD)
                [9 ]European Stroke Organisation (ESO)
                [10 ]European Heart Network (EHN)
                Article
                10.1177/2047487316653709
                27353126
                ad2a6ba3-8724-4a34-9092-fdef3a408273
                © 2016

                http://journals.sagepub.com/page/policies/text-and-data-mining-license

                History

                Comments

                Comment on this article